Skip to main content
. 2018;19(2):565–569. doi: 10.22034/APJCP.2018.19.2.565

Figure 3.

Figure 3

Percentage of Viable Cells of 4T1 Cells were Treated by EAF 10 µg/mL for 24; 48 and 72 h and Measured Viable Cells